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Abstract: Natural bone consists of hard nanostructured hydroxyapatite (HA) in a nanostructured 
protein-based soft hydrogel template (ie, mostly collagen). For this reason, nanostructured HA 
has been an intriguing coating material on traditionally used titanium for improving orthopedic 
applications. In addition, helical rosette nanotubes (HRNs), newly developed materials which 
form through the self-assembly process of DNA base pair building blocks in body solutions, 
are soft nanotubes with a helical architecture that mimics natural collagen. Thus, the objective 
of this in vitro study was for the ﬁ  rst time to combine the promising attributes of HRNs and 
nanocrystalline HA on titanium and assess osteoblast (bone-forming cell) functions. Different 
sizes of nanocrystalline HA were synthesized in this study through a wet chemical precipitation 
process following either hydrothermal treatment or sintering. Transmission electron microscopy 
images showed that HRNs aligned with nanocrystalline HA, which indicates a high afﬁ  nity 
between both components. Some of the nanocrystalline HA formed dense coatings with HRNs 
on titanium. More importantly, results demonstrated enhanced osteoblast adhesion on the HRN/
nanocrystalline HA-coated titanium compared with conventional uncoated titanium. Among all 
the HRN/nanocrystalline HA coatings tested, osteoblast adhesion was the greatest when HA 
nanometer particle size was the smallest. In this manner, this study demonstrated for the ﬁ  rst 
time that biomimetic HRN/nanocrystalline HA coatings on titanium were cytocompatible for 
osteoblasts and, thus, should be further studied for improving orthopedic implants.
Keywords: helical rosette nanotubes, nanocrystalline hydroxyapatite, biomimetic, titanium, 
osteoblast, self assembled
Introduction
Although conventionally synthesized biomaterials have been served well as orthopedic 
implants over the past half a century, high implant failure rates after 10–15 years of 
implantation necessitate improvement. For example, in the United States, nearly 11% of 
hip replacements and 8% of knee replacements were revision procedures of previously 
failed replacements in 2003 (AAOS 2003). One of many reasons for implant failure 
is the incompatibility between osteoblasts (bone-forming cells) and today’s implant 
materials such as titanium (Jayaraman et al 2004). One approach to improve such 
implant materials is to design implants which are more similar to natural bone, and this 
is a role envisioned for nanotechnology. To date, nanomaterials (that is, materials with 
basic structural units, grains, particles, ﬁ  bers, or other constituent components in the 
range of 1–100 nm [Siegel and Fougere 1995]) have exhibited enhanced cytocompat-
ibility, mechanical, and electrical properties compared with respective conventional 
micronscale materials. The nanostructural features, favorable surface chemistry, and 
bioactive surfaces of nanomaterials which mimic bone signiﬁ  cantly promote selective 
protein (such as vitronectin, ﬁ  bronectin, etc) adsorption and efﬁ  ciently stimulate new International Journal of Nanomedicine 2008:3(3) 324
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bone formation compared with conventional materials, thus, 
possibly serving as the next generation of orthopedic implant 
materials (Zhang et al 2008a).
One type of novel nanomaterial, helical rosette nanotubes 
(HRNs), are novel organic nanotubes that mimic the natural 
nanostructure of collagen and other components in bone. 
The DNA base pair building blocks of HRNs (the guanine-
cytosine motif) undergo self-assembly in body solutions to 
form a stable nanotube with a 3.5 nm outer diameter tube 
based on hydrogen bond formation, base-stacking interac-
tions and hydrophobic effects (Figure 1) (Fenniri et al 2001). 
Not only are HRNs biologically-inspired nanometric and 
helical architectures similar to collagen in bone, but they also 
can be functionalized with a diverse range of peptides (such 
as arginine-glycine-aspartic acid [RGD] and lysine) which 
have been known to enhance osteoblast functions. Previous 
studies have demonstrated the ability of HRNs to increase 
osteoblast adhesion as a coating material on titanium (Chun 
et al 2004, 2005).
Another major component in the bone matrix is hydroxy-
apatite (HA; Ca10(PO4)6(OH)2) which has been used as an 
orthopedic and dental implant material for decades (Hoexter 
2002; Sammarco and Chang 2002). HA is osteoconductive 
since its surface can undergo selective chemical reactiv-
ity with surrounding tissues, which results in a tight bond 
between bone and the implant. Moreover, studies have 
demonstrated that HA induced osteogenic differentiation 
of osteoblasts (Wang 2004). Recently, studies have further 
improved HA for orthopedic applications by coating nano-
meter (instead of micron) HA crystals on titanium matching 
the crystal size of HA in bone. Nanophase HA has excel-
lent cytocompatibility properties with osteoblasts (Chang 
et al 2006) and in vivo studies have demonstrated complete 
osseointegration of tantalum coated with nanophase HA 
after 2 weeks whereas tantalum coated with conventional 
(or micron) HA took up to 8 weeks (Sato 2006). As a result, 
these promising properties of nanophase HA and HRNs have 
highlighted the possibility that collectively they should be 
studied for orthopedic applications.
Thus, the objective of this study was to determine material 
and cytocompatibility properties (with osteoblasts) of HRN/
HA composites. In this study, a wet chemistry precipitation 
method was used to synthesize HA (Lopez-Macipe et al 
1998; Sato et al 2006). This process, via a mild reaction under 
room temperature, is similar to the biomineralization process 
of bone and teeth. In addition, wet chemistry enabled good 
control of the crystalline phase and surface morphology of 
HA at the micrometer and nanometer levels (Duan and Wang 
2006). Moreover, since grain size is one of the important 
factors which may inﬂ  uence the growth of osteoblasts on 
implant materials, several grain sizes of nanocrystalline HA 
in HRNs were fabricated here by utilizing different sintering 
temperatures or hydrothermal treatment regimes.
Materials and methods
Synthesis of HA and preparation 
of HRNs
A well-established wet chemistry process was used to 
synthesize HA (Lopez-Macipe et al 1998; Sato et al 2006). 
Brieﬂ  y, 37.5 ml of a 0.6 M ammonium phosphate (Sigma 
Aldrich, St. Louis, MO) solution was mixed with 375 ml of 
deionized water (dH2O) while ammonium hydroxide (Fisher 
Scientiﬁ  c, Waltham, MA) was used to adjust the solution 
pH to around 10. 45 ml of a 1 M calcium nitrate (Sigma 
Aldrich) solution was slowly dripped into the above mixture 
over 12 min while stirring. Precipitation of HA continued 
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Figure 1 Schematic illustration of the hierarchical assembly of HRNs with a lysine side chain (HRN-K1). (A) The DNA base pair building blocks (Guanine-cytosine, G^C motif) 
and lysine side chain, (B) Six G^C motifs assemble into a rosette supermacrocycle by the formation of 18 H-bonds, and (C) The rosettes stack up to form a stable 3.5 nm 
diameter HRN with a 11 Å inner tube channel.International Journal of Nanomedicine 2008:3(3) 325
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for 10 min at room temperature. Then, the solution with 
HA precipitates was treated hydrothermally at 200 °C for 
20 h in a 125 ml Teﬂ  on liner (Parr Instrument, Moline, IL) 
(Ioku and Yoshimura 1991). This hydrothermal treatment 
method produced small grain sizes of nanocrystalline HA 
at relatively low temperatures but under a higher pressure 
(Sato et al 2005). After 20 h, the nanocrystalline HA was 
centrifuged and rinsed sequentially with dH2O three times, 
then dried at 80 °C for 12 h.
Larger grain sizes and higher yield rates of nano HA 
can be obtained without hydrothermal treatment. For this, 
1 M calcium nitrate was slowly added to 0.6 M ammonium 
phosphate, while ethanol was used to disperse the mixture 
and ammonium hydroxide to adjust the pH up to 12. The 
mixture was then slightly heated at 40 °C for 1h and HA 
precipitated at room temperature for 24 h. The HA white 
powder was obtained after washing and centrifugation and 
was dried similar to the method described above. Then, 
the HA powder was sintered at 700 °C for 6 h to achieve a 
large nanocrystalline HA grain size or at 550 °C for 6 h to 
produce a middle nanocrystalline HA grain size.
HRNs with lysine side chain (HRN-K1) building blocks 
were synthesized by using a general synthetic strategy 
(Fenniri et al 2001). In total, six main intermediate products 
were synthesized in 16 steps of synthesis reactions to obtain 
HRN-K1 building blocks. Then, HRN-K1 building blocks 
were dissolved in dH2O to achieve a 0.1 mg/ml stock solution. 
0.001 mg/ml HRN-K1 solution was prepared by diluting the 
stock solution with dH2O. Solutions were sterilized with a 
0.22 μm syringe ﬁ  lter (Chun et al 2004).
HRN and HA coatings on titanium
Titanium (Ti, 1 cm × 1 cm × 0.2 cm; SupraAlloys, Camarillo, 
CA) was cleaned according to standard procedures (Chun et al 
2004). 250 mg of each type of nano HA (speciﬁ  cally, small, 
middle and large HA grain sizes) was mixed with 5 ml 70% 
ethanol and sonicated for 20 min to obtain a homogenous 
HA solution. Then, 5 ml of 0.001 mg/ml HRN-K1 solution 
was added into each of the above mixtures. Nano HA and 
HRN-K1 were coated on the titanium surface by absorption 
for 45 minutes at room temperature and dried overnight. In 
addition, 0.001 mg/ml HRN-K1 without HA was coated on 
titanium. Uncoated titanium served as controls.
HRN and HA characterization
HRNs have been fully characterized as described else-
where (Fenniri et al 2001; Chun et al 2004, 2005). The 
nanocrystalline HA powders were characterized by 
X-ray diffraction (XRD; Siemens Diffraktometer D5000). 
Nanocrystalline HA, HRNs, and the combination of HRNs 
with nano HA were characterized with TEM (Philips, 
EM410 PW6008). The agglomerated mean particle size was 
determined by a particle size analyzer (Nano ZS, Malvern 
Instruments). The HRN/nanocrystalline HA coatings were 
characterized with SEM (LEO 1530-VP).
Osteoblast experiments
Osteoblast adhesion was determined on: (1) 0.001 mg/ml 
HRN-K1 with the small grain size nanocrystalline HA (pre-
pared by the hydrothermal treatment) coated on titanium, 
(2) 0.001 mg/ml HRN-K1 with the middle grain size nano 
HA (prepared by sintering at 550 °C) coated on titanium, (3) 
0.001 mg/ml HRN-K1 with the large grain size nanocrystal-
line HA (prepared by sintering at 700 °C) coated on titanium, 
(4) 0.001 mg/ml HRN-K1 alone coated on titanium, and (5) 
uncoated titanium. Human fetal osteoblasts (bone-forming 
cells, ATCC, CRL-11372, population numbers 8–10) were 
seeded at 3500 cells/cm2 onto the above ﬁ  ve substrates 
and were cultured in Dulbecco’s modiﬁ  ed eagle’s medium 
(DMEM; Gibco/BRL, Grand Island, NY) supplemented with 
10% fetal bovine serum (FBS; HyClone, Logan, UT) and 
1% penicillin/streptomycin (P/S; Hyclone) under standard 
cell culture conditions (37 °C, a humidiﬁ  ed, 5% CO2/95% 
air environment) for 4 h. After the prescribed time period, 
nonadherent cells were removed by washing with phosphate 
buffered saline (PBS). Adherent cells were then ﬁ  xed with 
10% normal buffered formalin (NBF; Fisher Scientiﬁ  c), 
stained with 4’,6-diamidino-2-phenylindole, dihydrochloride 
(DAPI; Invitrogen, Carlsbad, CA) and counted on ﬁ  ve ran-
dom ﬁ  elds of view for each substrate using a Zeiss Axiovert 
200M ﬂ  uorescence microscope.
Statistical analysis
Experiments were run in triplicate and repeated three separate 
times for each substrate. Data were represented by the mean 
value with the standard error of the mean (SEM) noted. A 
student’s t-test was used to check statistical signiﬁ  cance 
between means and p   0.1 was considered statistically 
signiﬁ  cant.
Results and discussion
Particle synthesis and the afﬁ  nity 
between HRN-K1 and HA
In the present study, different grain sizes and morphologies 
of nanocrystalline HA were synthesized using two treatment International Journal of Nanomedicine 2008:3(3) 326
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methods. TEM images showed that HA precipitates did 
not have clear demarkation lines or regular shapes before 
hydrothermal treatments or sintering (Figure 2A). Rod-like 
nanocrystalline HA particles were synthesized after hydro-
thermal treatment (~50–100 nm in length and 20–30 nm 
in width; Figure 2B) and after sintering at 700 °C for 6 h 
(~100–170 nm in length and 20–30 nm in width; Figure 2D). 
In addition, sintering HA powers at 550 °C for 6 h produced 
a middle grain size of irregular nanocrystallized HA with a 
more agglomerated morphology (Figure 2C). Most impor-
tantly, Figure 2E showed for the ﬁ  rst time a good afﬁ  nity 
between HRN-K1 and nanocrystalline HA. Speciﬁ  cally, a 
Figure 2 TEM images of (A) HA precipitates before sintering, (B) small grain size nanocrystalline HA (prepared by hydrothermal treatment), (C) middle grain size nanocrystalline 
HA (prepared by sintering at 550 °C) with the inset at high magniﬁ  cation, scale bar of the inset image is 20 nm, (D) large grain size nanocrystalline HA (prepared by sintering 
at 700 °C), (E) 0.01 mg/ml HRN-K1 with small grain size nanocrystalline HA (hydrothermal treatment nano HA served as a model); inset shows the enlarged region of 
(E) demonstrating the close HRN/HA interaction, and (F) 0.01 mg/ml HRN-K1 only.   Arrows show the HRN-K1.
(A) (B)
(C) (D)
(E) (F)International Journal of Nanomedicine 2008:3(3) 327
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bundle of HRN-K1 attached and oriented on nanocrystalline 
HA surfaces by simple adsorption.
Furthermore, by measuring the sizes of nanocrystalline 
HA in TEM images, Figure 3 provided quantiﬁ  ed results of 
the average HA grain sizes after hydrothermally treatment 
and sintering which demonstrated that hydrothermal treat-
ment can yield much smaller crystallite sizes than other 
methods. Speciﬁ  cally, nanocrystalline HA prepared by the 
hydrothermal treatment had an average grain size of 82.84 nm 
(in length) while nanocrystalline HA particles prepared by 
sintering at either 550 °C or 700 °C had average grain sizes 
of 90.01nm and 129.81nm, respectively.
In addition, XRD provided evidence that crystalline 
HA was present in all particles (Figure 4). Hydrothermally 
treated nanocrystalline HA displayed small amounts of peak 
broadening (Figure 4A), which supports the previously 
mentioned data of smaller crystallite sizes of hydrothermal 
nano HA compared with the other two types of sintered nano 
HA (Figure 4B and 4C). Moreover, consistent with previous 
studies (Sato et al 2006; Balasundaram et al 2006), all types 
of nanocrystalline HA agglomerated into micron sizes and 
hydrothermally prepared nanocrystalline HA agglomerated 
into smaller sizes than sintered nanocrystalline HA. 
Speciﬁ  cally, hydrothermally treated HA and HA sintered 
at either 550 °C or at 700 °C had ~1.51, 3.32, and 1.61 μm 
agglomerated mean particle sizes (Table 1), respectively. A 
previous study demonstrated that conventional (or micron) 
HA agglomerated up to 169 μm (Balasundaram et al 
2006). The signiﬁ  cant larger agglomeration sizes of the 
middle grain sizes nanocrystalline HA may be due to more 
irregular shapes of HA and possibly greater hydrophobic 
surface chemistry that increased agglomeration after 
sintering at 550 °C when compared with the regular rod-like 
hydrothermal HA. Moreover, Table 1 showed that sintering 
HA precipitates to either 550 °C or 700 °C achieved higher 
yield rates of nanocrystalline HA (86.46% and 83.51%) than 
nanocrystalline HA prepared by hydrothermal treatments 
(69.54%). The longer HA precipitation time (24 h) before 
sintering most likely contributed to the higher yield rates 
of nanocrystalline HA prepared by sintering (whereas only 
a 10 minute precipitation was used for the hydrothermal 
treatment).
Characterization of HRN and HA 
coatings on titanium
SEM images showed that thin layers of different size dis-
tributions of nanocrystalline HA in 0.001 mg/ml HRN-K1 
were coated on titanium (Figure 5). All of the nanocrystalline 
HA with HRN coatings exhibited agglomerated nanocrystal-
lites. Uncoated titanium had micron roughness with large 
grain sizes; speciﬁ  cally, small grain sizes of nanocrystal-
line HA with HRNs revealed dense HA rod crystallite 
agglomerations (Figure 5A and 5B). Middle grain sizes of 
nanocrystalline HA with HRN coatings also showed very 
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Figure 3 The comparison of average grain sizes of nanocrystalline HA under different synthesis treatments. Data are mean ± SEM; n = 50. *p   0.0001 when compared with 
small grain size nanocrystalline HA (prepared by hydrothermal treatment), and **p   0.0001 when compared with large grain size nanocrystalline HA (prepared by sintering 
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dense crystallite agglomerations but irregular crystalline 
distributions (Figure 5C and 5D) which was consistent with 
TEM and Table 1 results. In contrast, large grain sizes of 
nanocrystalline HA with HRN coatings exhibited the largest 
HA rod crystallite assemblies with a loose connecting pattern 
compared with the other coatings (Figure 5E and 5F). TEM 
clearly demonstrated intimate interactions between HRNs 
and HA when coated on titanium.
Osteoblast adhesion
Results from the cytocompatibility tests provided the ﬁ  rst 
evidence of greater osteoblast adhesion on nanocrystalline 
HA/HRN coatings on titanium compared with uncoated tita-
nium (Figure 6). Speciﬁ  cally, the small and middle grain sizes 
of nanocrystalline HA/HRN coatings increased osteoblast 
adhesion by 29.3% and 36.3% on titanium compared with 
uncoated titanium, respectively. At the same time, the small 
and middle grain size nanocrystalline HA/HRN coatings also 
increased osteoblast adhesion more than on the large grain 
size nanocrystalline HA/HRN coatings. In fact, it has been 
demonstrated that nanophase materials improved speciﬁ  c 
protein (such as ﬁ  bronectin and vitronectin) interactions 
which contributed to enhanced osteoblast functions on 
nanophase materials compared with large grain size conven-
tional materials (Webster et al 2000). For example, Webster 
and colleagues (2000) showed that there was signiﬁ  cantly 
enhanced osteoblast adhesion on bulk nanophase HA (67 nm) 
compared with conventional HA (179 nm HA) due to greater 
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Figure 4 XRD of nanocrystalline HA. (A) Small grain size nanocrystalline HA (prepared by hydrothermal treatment), (B) middle grain size nanocrystalline HA (prepared by 
sintering at 550 °C), and (C) large grain size nanocrystalline HA (prepared by sintering at 700 °C).
Table 1 Summary of the nanocrystalline HA yield rates, grain and agglomerated sizes
Types Yield rates Average grain sizes Agglomerated mean size
Small grain size nanocrystalline HA 
(hydrothermally treated at 200°C for 20 h)
69.54% 82.84 nm 1512.5 nm
Middle grain size nanocrystalline HA 
(sintered at 550°C for 6 h)
86.46% 90.01 nm 3323.5 nm
Large grain size nanocrystalline HA 
(sintered at 700°C for 6 h)
83.51% 129.81 nm 1609.9 nm
HA precipitates (before hydrothermal 
treatment or sintering)
_ 113.64 nm 2278.6 nmInternational Journal of Nanomedicine 2008:3(3) 329
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Figure 5 SEM micrographs of (A) low magniﬁ  cation and (B) high magniﬁ  caition small grain size nanocrystalline HA (prepared by hydrothermal treatment) with 0.001 mg/ml 
HRN-K1 coated on titanium; (C) low magniﬁ  cation and (D) high magniﬁ  cation of middle grain size nanocrystalline HA (prepared by sintering at 550 °C) with 0.001 mg/ml HRN-K1 
coated on titanium; (E) low magniﬁ  cation and (F) high magniﬁ  caition of large grain size nanocrystalline HA (prepared by sintering at 700 °C) with 0.001 mg/ml HRN-K1 coated 
on titanium; (G) titanium coated with 0.001 mg/ml HRN-K1 and (H) uncoated titanium.   Arrows show the single HA crystallites.
(A)  (B) 
(C)  (D) 
(E)  (F) 
(G)  (H) International Journal of Nanomedicine 2008:3(3) 330
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amounts of vitronectin (a protein known to mediate anchor-
age-dependent cell adhesion [Webster 2001]) adsorption.
In the present study, a grain size-dependent osteoblast 
adhesion was also observed for the small and middle grain 
sizes of nano HA/HRN coatings compared with the large 
grain size HA/HRN coatings. In addition, osteoblast attach-
ment signiﬁ  cantly improved on the 0.001 mg/ml HRN-K1 
coated titanium (alone) which is consistent with previous 
studies (Chun et al 2004, 2005). Importantly, although the 
bone remodeling process in vivo includes various cell types 
(such as osteoblasts, osteoclasts, and osteocytes) (Webster 
2001), promoting initial osteoblast adhesion on orthopedic 
implant materials is essential for further new bone growth. 
Therefore, the signiﬁ  cantly enhanced osteoblast adhesion 
on nanocrystalline HA/HRN coatings observed in this study 
indicates promise for the continued investigation of these bio-
mimetic coatings for improving orthopedic implants. Clearly, 
however, future studies will have to evaluate the long-term 
functions of osteoblasts as well as determine the functions 
of additional cells necessary for maintaining healthy, strong 
bones in the body.
As is known, inorganic nanocrystalline HA and elastic 
collagen (which has helical nanostructures) assemble to form 
the natural bone matrix (Kaplan et al 1994; Webster 2001). 
Thus, much effort has been devoted to apply bioactive and 
osteoconductive nano HA materials as coatings on implant 
materials for orthopedic applications (Webster et al 2002; 
Choi et al 2004; Bigi et al 2005; Sato et al 2005, 2006, 
2007; Balasundaram et al 2006; Evis et al 2006; Narayanan 
et al 2008; Teng et al 2008; Ciobanu et al 2007; Shibli and 
Mathai 2008). For instance, recently it has been reported that 
enhanced cell functions were observed on titanium coated 
with nano HA by an electrochemical method (Narayanan et al 
2008). However, current HA coatings still can not satisfy 
patients’ high expectations for orthopedic implants due to 
many shortcomings (ie, lack of rapid osseointegration, low 
degree of crystallinity, weak interactions with titanium, etc). 
In this study, it should be emphasized that novel nanotubular 
HRNs, which are coated with a high degree of nanocrystalline 
HA on titanium, not only possess ﬂ  exible functionalizable 
chemistries but also have biologically-inspired surface fea-
tures which may create favorable bone-like environments to 
improve osseointegration with juxtaposed bone.
For instance, HRNs have potential to serve as a biomi-
metic template for HA deposition. Figure 7C shows that HA 
crystals were rapidly formed on HRNs when mixed with 
CaCl2 and Na2HPO4 solutions for 2 minutes and were regu-
larly aligned on HRNs in a pattern similar to the HA/collagen 
pattern in bone. Figure 7D shows randomly agglomerated HA 
on grids without HRNs. Because the deposition, nucleation 
and growth of HA crystals in pores of an extracellular col-
lagen matrix are important steps during bone remodeling in 
vivo, it can be anticipated that the HRN/HA coatings formu-
lated in this study not only mimic the nanostructure of bone 
0
400
800
1200
1600
2000
2400
2800
*
***
*
** *
Nanocrystalline HA with 0.001 mg/ml HRN-K1 coated on titanium
O
s
t
e
o
b
l
a
s
t
 
a
d
h
e
s
i
o
n
 
d
e
n
s
i
t
y
 
(
c
e
l
l
s
/
c
m
2
)
Uncoated titanium 0.001 mg/ml HRN-K1
coated on titanium
Large grain size
nanocrystalline HA
(sintered at 700ºC)
Middle grain size
nanocrystalline HA
(sintered at 550ºC)
Small grain size
nanocrystalline HA
(hydrothermal
treatment) 
Figure 6. Osteoblast adhesion on HA and HRN-K1-coated titanium. Data are mean ± SEM; n = 9.
Notes: *p   0.05 when compared to uncoated titanium; **p   0.01 and ***p   0.1 when compared with large grain size nanocrystalline HA (prepared by sintering at 700°C) 
with 0.001 mg/ml HRN-K1 coated on titanium.International Journal of Nanomedicine 2008:3(3) 331
Biomimetic helical rosette nanotubes and nanocrystalline hydroxyapatite coatings
but also resemble the HA/collagen self-assembly process to 
promote natural mineralization (Figure 7).
In addition, although there were no statistical differences 
in osteoblast adhesion among the HRNs coated on titanium 
and nanocrystalline HA/HRN coated on titanium (due to 
the possibly different concentrations of exposed HRNs on 
their surfaces), creating a biomimetic coating on titanium 
is promising to promote osteoblast adhesion and long term 
(C) (D)
(A)
(B)
Titanium
Collagen
Coating nano HA and
HRNs on titanium
Nanoroughness and
biomimetic coatings on
titanium
HRNs HA HA
Triple helix of collagen and nano HA
crystals in the bone matrix
Biologically-inspired helical rosette
nanotubes and nanocrystalline HA coating
2μm 2μm
Figure 7 A biologically-inspired nanocrystalline HA/HRN coating. (A) The schematic illustration of coating nano HA/HRN on titanium, (B) the nanostructured HA/HRN coating 
mimics the natural bone matrix which consists in part of triple helices of collagen assembled with nanocystalline HA, (C) SEM images of biomimetic HA with 0.1 mg/ml HRN-
K1 coating on a porous carbon TEM grid (prepared by reacting CaCl2 with Na2HPO4 for 2 minutes on a TEM grid covered by HRN-K1), and (D) only HA coating on TEM grid 
(control, 2 minute reaction).International Journal of Nanomedicine 2008:3(3) 332
Zhang et al
bone tissue formation possibly contributing to lower implant 
failure rates.
Importantly, nano HA/HRNs were coated on titanium by 
adsorption, which was adopted as a model coating method 
in this study. This coating method could be improved by 
using commercially available coating techniques (such as 
the widely used plasma-spray process, sol-gel processing, 
spin coating, electrospinning, newly developed IonTiteTM 
methods [Sato et al 2006], etc), which may contribute to 
more surface coverage and coating strength for orthopedic 
applications.
Lastly, previous studies have demonstrated that HRN-K1 
have the potential to increase new bone growth when coated 
on titanium or hydrogels because of its nanoscale biologi-
cally-inspired features and rich lysine moieties (Chun et al 
2004; Zhang et al 2008b). In the current study, the concen-
tration of HRNs that osteoblasts interacted with was below 
0.001 mg/ml due to dilution effects of co-coating HRNs 
and HA (eg, some HRNs may be underneath the HA and 
not exposed on the surface). Since it has been demonstrated 
that higher concentrations of HRNs on hydrogels (such as 
0.01 mg/ml) can enhance osteoblast adhesion compared 
with low HRN concentration coatings (Zhang et al 2008b), 
it anticipated that increasing HRN concentration on the 
HA/HRN coating can further augment osteoblast adhesion. 
Clearly, this should be the focus of further studies.
Conclusions
In summary, different grain sizes of nanocrystalline HA were 
synthesized in this study and co-coated with a low concentra-
tion (speciﬁ  cally, 0.001 mg/ml) of HRN-K1 on titanium. The 
present study demonstrated that HRNs had a high afﬁ  nity 
with nanocrystalline HA. Furthermore, biomimetic nano HA/
HRN coatings offer advantages over traditional orthopedic 
implant materials (such as uncoated titanium) by enhancing 
osteoblast adhesion and, thus, deserve further investigation 
for improving orthopedic applications.
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